American Portfolios Advisors’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$127K Sell
3,335
-100
-3% -$5.01K 0.01% 1216
2022
Q2
$187K Sell
3,435
-187
-5% -$10.3K 0.01% 1077
2022
Q1
$226K Buy
3,622
+915
+34% +$60.2K 0.01% 1107
2021
Q4
$272K Buy
2,707
+322
+14% +$28.3K 0.01% 1000
2021
Q3
$215K Sell
2,385
-1,502
-39% -$137K 0.01% 1082
2021
Q2
$358K Buy
3,887
+403
+12% +$32.2K 0.01% 869
2021
Q1
$337K Buy
3,484
+1,294
+59% +$134K 0.01% 822
2020
Q4
$114K Buy
2,190
+747
+52% +$31.2K 0.01% 1101
2020
Q3
$57.8K Buy
1,443
+443
+44% +$13.9K ﹤0.01% 1270
2020
Q2
$16K Hold
1,000
﹤0.01% 1741
2020
Q1
$10.8K Buy
+1,000
New +$13.9K ﹤0.01% 1781

Other funds holding FLGT

American Portfolios Advisors's FLGT Position: Q3 2022 in Review

American Portfolios Advisors reduced its Fulgent Genetics (FLGT) stake by 2.9% in Q3 2022, selling an estimated $5.01K and leaving 3,335 shares worth $127K. The position accounts for 0.01% of the portfolio, ranked #1216.

American Portfolios Advisors first reported a position in FLGT in Q1 2020 and has held it in 11 quarters since. The position peaked at $358K in Q2 2021. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

  • American Portfolios Advisors held 3,335 shares of Fulgent Genetics worth $127K as of Q3 2022.
  • American Portfolios Advisors sold 100 Fulgent Genetics shares in Q3 2022, an estimated $5.01K.
  • Fulgent Genetics made up 0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1216 holding.
  • American Portfolios Advisors first reported a position in Fulgent Genetics in Q1 2020 and has held it in 11 quarters since.
  • American Portfolios Advisors's Fulgent Genetics position peaked at $358K in Q2 2021.
  • 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.